Skip to main content
. 2015 Nov 19;7:104. doi: 10.1186/s13098-015-0102-8

Fig. 1.

Fig. 1

Luseogliflozin improved elevated glucose concentrations and normalized HFDT feeding-induced hepatosteatosis. a Control, NA/STZ/HFDT and NA/STZ/HFDT/Luseo mice. b, c Blood glucose and insulin concentrations in fasted states. d Whole body and liver weights. e Serum ALT level. f Serum triglyceride, cholesterol and non-esterified fatty acids (NEFA) levels. All data are shown as means + SEM